ETE-12862-81579
4 vaccinations
9 coded responses
23 check-ins
9 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 550 / MN
- Registered
- 2021-03-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-17
Registered in v-safe
-
2021-03-17
Dose 1 — Moderna
-
2021-03-17
Survey response — day 0, dose 1MedDRA: Pre-existing disease — Feeling: Fair · Site: Pain, ItchingFree text: I have many of these symptoms, but they are standard for me so its impossible to tell if they are related to the vaccine or notMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-18
Survey response — days 1–6 daily, dose 1MedDRA: Fatigue — Feeling: Fair · Site: Pain, Swelling · Chills, Headache, Fatigue or tirednessFree text: Other symptoms are normal for me, fatigue worse than baselineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-19
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness, Abdominal painAdult check-in
-
2021-03-20
Survey response — days 1–6 daily, dose 1MedDRA: No adverse event — Feeling: Fair · Site: Swelling · Headache, Fatigue or tiredness, Nausea, Abdominal painFree text: All normal day to day symptoms as wellMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-21
Survey response — days 1–6 daily, dose 1MedDRA: Injection site bruising — Feeling: Fair · Headache, Joint painsFree text: Bruising at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-24
Survey response — day 7, dose 1MedDRA: Pre-existing disease — Feeling: GoodFree text: None to an unusual degree (many are symptoms of chronic conditions I have)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-31
-
2021-04-07
Survey response — day 21, dose 1MedDRA: Condition aggravated, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Worsening of suspected gastroparesis, which I suspect is unrelated to vaccinationMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-14
Dose 2 — Moderna
-
2021-04-14
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-04-15
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-16
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Joint pains, Fatigue or tiredness, Nausea, Abdominal painAdult check-in
-
2021-04-17
Survey response — days 1–6 daily, dose 2MedDRA: Dyspnoea, Dyspnoea exertional — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Shortness of breath on standing (relieved by lying down)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-19
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tiredness, Nausea, Abdominal painAdult check-in
-
2021-04-20
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-04-21
- 2021-04-28
- 2021-05-07
- 2021-05-14
- 2021-07-14
-
2021-11-29
Dose 3 — Janssen/Johnson & Johnson
-
2022-09-16
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-09-30
Survey response — day 14, dose 4MedDRA: Erythema, Pruritus, Skin hypertrophy — Feeling: FairFree text: A few red, thickened, itchy patches of skinMedDRA releases: 2024-11 · check-in free text available
-
2022-10-16
Survey response — day 28, dose 4MedDRA: Mast cell activation syndrome, Medical counselling — Feeling: FairFree text: Worsening symptoms of what multiple doctors have described as mast cell dysfunctionMedDRA releases: 2024-11 · check-in free text available
- 2022-10-31
- 2022-12-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-17 | Moderna | |
| 2 | 2021-04-14 | Moderna | |
| 3 | 2021-11-29 | Janssen/Johnson & Johnson | No |
| 4 | 2022-09-16 | Pfizer-BioNTech | Flu |
Free text
Release 5 — day 0, dose 1
Systemic reaction (other): I have many of these symptoms, but they are standard for me so its impossible to tell if they are related to the vaccine or not
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Other symptoms are normal for me, fatigue worse than baseline
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): All normal day to day symptoms as well
Systemic reaction (other): Bruising at injection site
Release 6 — day 7, dose 1
Systemic reaction (other): None to an unusual degree (many are symptoms of chronic conditions I have)
Release 7 — day 21, dose 1
Symptoms: Worsening of suspected gastroparesis, which I suspect is unrelated to vaccination
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Shortness of breath on standing (relieved by lying down)
Release 12 — day 14, dose 4
Symptoms: A few red, thickened, itchy patches of skin
Release 12 — day 28, dose 4
Symptoms: Worsening symptoms of what multiple doctors have described as mast cell dysfunction
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Condition aggravated | ✓ | ✓ | ✓ |
| SD | Erythema | · | · | ✓ |
| SD | Mast cell activation syndrome | · | · | ✓ |
| SD | Medical counselling | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Pruritus | · | · | ✓ |
| SD | Skin hypertrophy | · | · | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
| SRO | Dyspnoea exertional | ✓ | ✓ | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Injection site bruising | ✓ | ✓ | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release